220 related articles for article (PubMed ID: 27861221)
21. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
[TBL] [Abstract][Full Text] [Related]
22. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
23. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
[TBL] [Abstract][Full Text] [Related]
24. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
25. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
[TBL] [Abstract][Full Text] [Related]
26. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
[TBL] [Abstract][Full Text] [Related]
27. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
[TBL] [Abstract][Full Text] [Related]
28. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
[TBL] [Abstract][Full Text] [Related]
29. Myotonia in DNM2-related centronuclear myopathy.
Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
[TBL] [Abstract][Full Text] [Related]
30. Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.
Jeub M; Bitoun M; Guicheney P; Kappes-Horn K; Strach K; Druschky KF; Weis J; Fischer D
Clin Neuropathol; 2008; 27(6):430-8. PubMed ID: 19130742
[TBL] [Abstract][Full Text] [Related]
31. Centronuclear (myotubular) myopathy.
Jungbluth H; Wallgren-Pettersson C; Laporte J
Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
[TBL] [Abstract][Full Text] [Related]
32. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and biopsy-based myopathological features of 5 cases with centronuclear myopathy].
Li HH; Liu SP; Li W; Zhao YY; Wu JL; Li DN; Yan CZ
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):856-9. PubMed ID: 19099905
[TBL] [Abstract][Full Text] [Related]
34. A rare case of centronuclear myopathy with
Aghbolaghi AG; Lechpammer M
Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
[TBL] [Abstract][Full Text] [Related]
35. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
36. Zebrafish as a Model to Investigate Dynamin 2-Related Diseases.
Bragato C; Gaudenzi G; Blasevich F; Pavesi G; Maggi L; Giunta M; Cotelli F; Mora M
Sci Rep; 2016 Feb; 6():20466. PubMed ID: 26842864
[TBL] [Abstract][Full Text] [Related]
37. Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review.
Zhang G; Xu M; Huang T; Lin W; Chen J; Chen W; Chang X
BMC Pediatr; 2021 Apr; 21(1):209. PubMed ID: 33926407
[TBL] [Abstract][Full Text] [Related]
38. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort.
Catteruccia M; Fattori F; Codemo V; Ruggiero L; Maggi L; Tasca G; Fiorillo C; Pane M; Berardinelli A; Verardo M; Bragato C; Mora M; Morandi L; Bruno C; Santoro L; Pegoraro E; Mercuri E; Bertini E; D'Amico A
Neuromuscul Disord; 2013 Mar; 23(3):229-38. PubMed ID: 23394783
[TBL] [Abstract][Full Text] [Related]
39. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
[TBL] [Abstract][Full Text] [Related]
40. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
